Kemal Caglar Gogebakan

7PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersStochastic analysis and modellingGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 16, 2026
Expected late-stage reduction under extended screening in the first multicancer screening trial.

|Aug 14, 2025
Estimating the Opportunity for Early Detection of Ovarian Cancer Using Individual-Patient Data from a Large Randomized Controlled Trial.

Marc D Ryser, Shannon T Holloway, Raphaël Morsomme

|Mar 20, 2024
Projecting the Impact of Multi-Cancer Early Detection on Late-Stage Incidence Using Multi-State Disease Modeling.

Jane M Lange, Kemal Caglar Gogebakan, Roman Gulati

|Jun 01, 2023
Short-term Endpoints for Cancer Screening Trials: Does Tumor Subtype Matter?

Lukas Owens, Kemal Caglar Gogebakan, Usha Menon

|Nov 02, 2022
Modeling the impact of novel systemic treatments on lung cancer screening benefits.

Kemal Caglar Gogebakan, Jane Lange, Christopher G Slatore

|Mar 14, 2022
Non-parametric seasonal unit root tests under periodic non-stationary volatility.

Kemal Çag Lar Gög Ebakan, Burak Alparslan Eroglu

Pageof 2